The Valley Desk

NCT02182830 · Interventional trial

24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension

Overall registry status Completed

Phase 3

Conditions Diabetes Mellitus, Type 2, Hypertension

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov